Cargando…
A Transversal Approach Combining In Silico, In Vitro and In Vivo Models to Describe the Metabolism of the Receptor Interacting Protein 1 Kinase Inhibitor Sibiriline
Sibiriline is a novel drug inhibiting receptor-interacting protein 1 kinase (RIPK1) and necroptosis, a regulated form of cell death involved in several disease models. In this study, we aimed to investigate the metabolic fate of sibiriline in a cross-sectional manner using an in silico prediction, c...
Autores principales: | Pelletier, Romain, Gicquel, Thomas, Simoes Eugenio, Mélanie, Ferron, Pierre-Jean, Morel, Isabelle, Delehouzé, Claire, Dimanche-Boitrel, Marie-Thérèse, Rousselot, Morgane, Le Daré, Brendan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787481/ https://www.ncbi.nlm.nih.gov/pubmed/36559159 http://dx.doi.org/10.3390/pharmaceutics14122665 |
Ejemplares similares
-
Nigratine as dual inhibitor of necroptosis and ferroptosis regulated cell death
por: Delehouzé, Claire, et al.
Publicado: (2022) -
Arylcyclohexylamine Derivatives: Pharmacokinetic, Pharmacodynamic, Clinical and Forensic Aspects
por: Pelletier, Romain, et al.
Publicado: (2022) -
Betulin, a Newly Characterized Compound in Acacia auriculiformis Bark, Is a Multi-Target Protein Kinase Inhibitor
por: Ahmadu, Augustine A., et al.
Publicado: (2021) -
New insights into quetiapine metabolism using molecular networking
por: Le Daré, Brendan, et al.
Publicado: (2020) -
Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients
por: Ferron, Pierre-Jean, et al.
Publicado: (2021)